Go back to the Europarl portal

Choisissez la langue de votre document :

  • bg - български
  • es - español
  • cs - čeština
  • da - dansk
  • de - Deutsch
  • et - eesti keel
  • el - ελληνικά
  • en - English (Selected)
  • fr - français
  • ga - Gaeilge
  • hr - hrvatski
  • it - italiano
  • lv - latviešu valoda
  • lt - lietuvių kalba
  • hu - magyar
  • mt - Malti
  • nl - Nederlands
  • pl - polski
  • pt - português
  • ro - română
  • sk - slovenčina
  • sl - slovenščina
  • fi - suomi
  • sv - svenska
Parliamentary questions
24 May 2018
E-002776-18
Question for written answer
to the Commission
Rule 130
Rory Palmer (S&D)

 Subject:  Brexit impact assessments: medicines, pharmaceuticals and medical and healthcare products
 Answer(s) 

What impact assessments has the Commission completed on the possible impacts of Brexit on the supply of medicines, pharmaceuticals and medical and healthcare products between the UK and the EU and between the EU and the UK? Will the Commission publish any such impact assessments?

Last updated: 6 June 2018Legal notice